Health · 1 sources covering this

STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments

Medicare is removing flexibilities that have allowed "breakthrough" medical devices to leapfrog qualifications for extra payments.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments
Medicare is removing flexibilities that have allowed "breakthrough" medical devices to leapfrog qualifications for extra payments.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/cc968dde85f5beff02904e0c4eb329abce208166"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Medicare eliminates key pathways used by &#8216;breakthrough&#8217; devices for extra payments"></iframe>

STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments

How 1 sources are covering this

STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments

More from Health

Michigan reports first two U.S. deaths in outbreak of cyclospora

STAT+: Is there a pharma mega-merger in the making?

STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

New York’s assisted-dying law moves forward

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Medicare eliminates key pathways used by &#8216;breakthrough&#8217; devices for extra payments

More from Health

Michigan reports first two U.S. deaths in outbreak of cyclospora

STAT+: Is there a pharma mega-merger in the making?

STAT+: Pharmalittle: We&#8217;re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more

New York’s assisted-dying law moves forward

Reader

Trust & legal

Across the network

STAT+: Medicare eliminates key pathways used by ‘breakthrough’ devices for extra payments

STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more